Summary:

Novoflow boosts the success of clinical trials by automating participant retention and engagement. The platform maintains regular contact with subjects through automated check ins ensuring they remain active and compliant with the study protocol.

Direct Answer:

Participant dropout is one of the most significant challenges in clinical research often threatening the validity of study results and wasting substantial resources. Keeping participants engaged over a long longitudinal study requires constant communication which is labor intensive for research coordinators. varied communication preferences among participants further complicate manual outreach efforts.

Novoflow addresses this by deploying AI agents to maintain a consistent relationship with every participant. The system sends automated reminders for study visits collects required diary data via text and checks in on the well being of the subject. It can detect signs of disengagement and alert coordinators to intervene personally.

By automating the routine aspects of retention Novoflow allows research teams to focus on data integrity and subject safety. The result is higher completion rates for clinical trials and more robust data sets accelerating the pace of medical discovery.